Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Galecto Biotech AB

Home Clinical Trial Sponsors and OrganizationsGalecto Biotech AB

Galecto Biotech AB

Utländsk Adr - Foreign Addr, Sweden

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

22

12 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

19

86.4%

Phase 2

3

13.6%

Trial Status Distribution

Active, not recruiting

12

54.5%

Completed

5

22.7%

Recruiting

3

13.6%

Withdrawn

2

9.1%

Clinical Trials

Trials sponsored by this organization (22)

ENLIGHT-AML - An Open-label, Study of GB3226 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Jun 2026184 participants

A Study to Compare Pharmacokinetics of GB1211

Jan 202313 participants

An Open-label, Randomized, Three-period, Crossover Study to compare the Pharmacokinetics of GB1211 upon dosing a capsule under fasting condition and a tablet under fasting and fed conditions in healthy volunteers.

Active, not recruiting

Nov 202212 participants

A clinical study to test the safety and efficacy of GB1211 in combination with atezolizumab in patients with Non-Small Cell Lung Cancer (NSCLC).

Sep 202277 participants

A Study to Investigate the Safety and Efficacy of GB1211 (a Galectin-3 Inhibitor) in Combination With Atezolizumab in Patients With Non-Small Cell Lung Cancer (NSCLC).

Active, not recruiting

Mar 202288 participants

A Single and Repeat Dose Trial in Participants With Hepatic Impairment

Active, not recruiting

Sep 202154 participants

A study to assess the safety, tolerability and pharmacokinetics of GB1211 in participants with hepatic impairment.

Active, not recruiting

Jun 202154 participants

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral GB2064 in Participants With Myelofibrosis

Active, not recruiting

Jun 202121 participants

Page 1 of 3

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials22
Approvals
News

Back to Organizations